← Filings of LDOS

Tables in the 10-Q of Leidos Holdings, Inc.

43 tables with numbers, filed May 5, 2020. Each one downloads as a CSV for Excel or Google Sheets, with the filing's address in the last row. Only the layout is tidied (a "$" or ")" in a cell of its own is joined to its number); no value is changed. Open the filing on sec.gov ↗

Part I		Page
Item 1.	Financial Statements (Unaudited)	1
	Condensed Consolidated Balance Sheets	1
	Condensed Consolidated Statements of Income	2
	Condensed Consolidated Statements of Comprehensive Income	3
	Condensed Consolidated Statements of Equity	4
	Condensed Consolidated Statements of Cash Flows	5
	Notes to Condensed Consolidated Financial Statements	6

	April 3, 2020	January 3, 2020
	(in millions)
ASSETS
Cash and cash equivalents	$445		$668
Receivables, net	1,793		1,734
Other current assets	630		410
Total current assets	2,868		2,812
Property, plant and equipment, net	490		287

	Three Months Ended
	April 3, 2020	March 29, 2019
	(in millions, except per share amounts)
Revenues	$2,889		$2,577
Cost of revenues	2,494		2,221
Selling, general and administrative expenses	197		166
Acquisition, integration and restructuring costs	12		2
Equity earnings of non-consolidated subsidiaries	(6)		(4)

	Shares of common stock	Additional paid-in capital		Retained earnings	Accumulated other comprehensive loss	Leidos Holdings, Inc. stockholders' equity		Non-controlling interest	Total
	(in millions, except for per share amounts)
Balance at January 3, 2020	141		$2,587		$896		$(70)		$3,413	$4	$3,417
Cumulative adjustments related to ASU adoption					(1)				(1)		(1)
Balance at January 4, 2020	141		2,587		895		(70)		3,412	4	3,416
Net income	—		—		115		—		115	—	115
Other comprehensive loss, net of taxes	—		—		—		(115)		(115)	—	(115)
Issuances of stock	1		9		—		—		9	—	9

	Three Months Ended April 3, 2020
	Defense Solutions	Civil		Health	Total
	(in millions)
DoD and U.S. Intelligence Community	$1,285		$17		$124	$1,426
Other government agencies(1)	208		544		375	1,127
Commercial and non-U.S. customers	212		71		28	311
Total	$1,705		$632		$527	$2,864

	Three Months Ended March 29, 2019
	Defense Solutions	Civil		Health	Total
	(in millions)
DoD and U.S. Intelligence Community	$1,135		$17		$124	$1,276
Other government agencies(1)	156		511		302	969
Commercial and non-U.S. customers	199		87		28	314
Total	$1,490		$615		$454	$2,559

	Balance sheet line item	April 3, 2020		January 3, 2020
		(in millions)
Contract assets - current:
Unbilled receivables(1)	Receivables, net		$718			$735
Contract liabilities - current:
Deferred revenue	Accounts payable and accrued liabilities	$420			$400
Contract liabilities - non-current:
Deferred revenue	Other long-term liabilities		$8			$9

Cash	$18
Receivables		159
Other current assets	64
Operating lease right-of-use assets	25
Property, plant and equipment	161
Intangible assets	464
Accounts payable and accrued liabilities	(45)
Accrued payroll and employee benefits	(29)

	Weighted average amortization period	Fair value
	(in years)	(in millions)
Program intangibles	10	$430
Backlog intangibles	1	34
Total	9	$464

	April 3, 2020				January 3, 2020
	Gross carrying value	Accumulated amortization		Net carrying value	Gross carrying value	Accumulated amortization		Net carrying value
	(in millions)
Finite-lived intangible assets:
Program intangibles	$1,427		$(566)		$861		$1,003		$(536)	$467
Software and technology	102		(84)		18		102		(83)	19
Customer relationships	45		(7)		38		45		(6)	39
Backlog	34		(6)		28		—		—	—

	Defense Solutions	Civil		Health	Total
	(in millions)
Goodwill at December 28, 2018	$2,015		$1,924		$921	$4,860
Goodwill re-allocation	25		(25)		—	—
Acquisition of IMX Medical Management Services, Inc.	—		—		50	50
Divestiture of health staff augmentation business	—		—		(5)	(5)
Foreign currency translation adjustments	(4)		8		—	4
Adjustment to goodwill	3		—		—	3

Fiscal year ending
	(in millions)
2020 (remainder of year)	$142
2021	171
2022	166
2023	144
2024	100
2025 and thereafter	223

	Stated interest rate		Effective interest rate		April 3, 2020(1)		January 3, 2020(1)
					(in millions)
Senior unsecured bridge loan:
$1,250 million bridge loan, due January 2021	2.37%		4.00%		$1,238			$—
Senior unsecured term loan:
$1,925 million Term Loan A, due January 2025		2.37%		2.64%		1,906			—
Senior secured term loans:
$690 million Term Loan A, due August 2023	3.31%		3.74%		—			581

	Foreign currency translation adjustments	Unrecognized gain (loss) on derivative instruments		Pension adjustments	Total accumulated other comprehensive loss
	(in millions)
Balance at December 28, 2018	$(41)		$14		$(3)	$(30)
Other comprehensive income (loss)	5		(55)		(1)	(51)
Taxes	3		15		—	18
Reclassification from accumulated other comprehensive loss	—		(7)		—	(7)
Balance at January 3, 2020	(33)		(33)		(4)	(70)
Other comprehensive (loss) income	(76)		(55)		1	(130)

		Three Months Ended
	Income statement line item	April 3, 2020	March 29, 2019
		(in millions)
Sales-type leases:
Selling price at lease commencement	Revenues	$16		$10
Cost of underlying asset	Cost of revenues	(13)		(9)
Operating income		3		1
Interest income on lease receivables	Revenues	2		—

	April 3, 2020			January 3, 2020
	Carrying value	Fair value		Carrying value	Fair value
	(in millions)
Financial assets:
Derivatives	$5		$5		$2	$2
Financial liabilities:
Derivatives	$125		$125		$75	$75

	Asset derivatives
	Balance sheet line item	April 3, 2020	January 3, 2020
		(in millions)
Fair value interest rate swaps	Other current assets(1)	$4		$2
Foreign currency forward contracts	Other current assets	1			—
		$5		$2
(1) The carrying amount of the fair value interest rate swaps were recorded within "Other assets" as of January 3, 2020.
	Liability derivatives

	Carrying amount of hedged item			Cumulative amount of fair value adjustment included within the hedged item
Balance sheet line item of hedged item	April 3, 2020	January 3, 2020		April 3, 2020	January 3, 2020
	(in millions)
Long-term debt, current portion(1)	$454		$452		$4	$2

	Three Months Ended
Corporate	April 3, 2020	March 29, 2019		Dollar change	Percent change
	(dollars in millions)
Operating loss	$(35)		$(15)		$(20)	NM

Period	Total Number of Shares(or Units)Purchased (1)	Average Price Paid per Share (or Unit)		Total Number of Shares (or Units) Purchased as Part of Publicly Announced Repurchase Plans or Programs	Maximum Number of Shares (or Units) that May Yet Be Purchased Under the Plans or Programs
January 4, 2020 - January 31, 2020	4,703		$97.70		—	7,696,108
February 1, 2020 - February 29, 2020	—		—		—	7,696,108
March 1, 2020 - March 31, 2020	228		72.51		—	7,696,108
April 1, 2020 - April 3, 2020	—		—		—	7,696,108
Total	4,931		$96.54		—

Exhibit Number	Description of Exhibit
10.1		Sale Agreement dated as of February 3, 2020, by and among L3 Harris Technologies, Inc., Leidos Inc. and Leidos Holdings Inc. Incorporated by reference to Exhibit 2.1 to our Current Report on Form 8-K filed with the SEC on February 4, 2020.
10.2		Credit Agreement dated as of January 17, 2020, among Leidos Holdings, Inc., Leidos Inc. and Citibank, N.A. Incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed with the SEC on January 17, 2020.
10.3		Bridge Credit Agreement dated as of January 31, 2020, among Leidos Holdings, Inc., Leidos Inc. and Citibank, N.A. Incorporated by reference to Exhibit 4.1 to our Current Report on Form 8-K filed with the SEC on January 31, 2020.
10.4		Term Loan Credit Agreement dated as of February 12, 2020, among Leidos Holdings, Inc., Leidos, Inc. and Citibank, N.A. Incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed with the SEC on February 14, 2020.
31.1		Certification of Chairman and Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2		Certification of Executive Vice President and Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1		Certification of Chairman and Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

Tables in the 10-Q of Leidos Holdings, Inc.

Table 1 after “TABLE OF CONTENTS”

Table 2 after “CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)”

Table 3 after “CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)”

Table 4 after “CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)”

Table 5 after “CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED)”

Table 6 after “CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED)”

Table 7 after “CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)”

Table 8 after “Changes in estimates on contracts were as follows:”

Table 9 after “Disaggregated revenues by customer-type were as follows:”

Table 10 after “Disaggregated revenues by customer-type were as follows:”

Table 11 after “Disaggregated revenues by contract-type were as follows:”

Table 12 after “Disaggregated revenues by contract-type were as follows:”

Table 13 after “Disaggregated revenues by geographic location were as follows:”

Table 14 after “Disaggregated revenues by geographic location were as follows:”

Table 15 after “The components of contract assets and contract liabilities consisted of the following:”

Table 16 after “The preliminary fair values of the assets acquired and liabilities assumed at the Acquisition Date were as follows (in millions):”

Table 17 after “The following table summarizes the preliminary fair value of intangible assets acquired at the Acquisition Date and the related weighted ave”

Table 18 after “The following expenses were incurred related to the acquisition of Dynetics:”

Table 19 after “The pro forma information is not intended to reflect the actual results of operations that would have occurred if the acquisition had been c”

Table 20 after “The following table presents changes in the carrying amount of goodwill by reportable segment:”

Table 21 after “Intangible assets consisted of the following:”

Table 22 after “The estimated annual amortization expense as of April 3, 2020, was as follows:”

Table 23 after “The components of lease income were as follows:”

Table 24 after “The financial instruments measured at fair value on a recurring basis consisted of the following:”

Table 25 after “The fair value of the interest rate swaps and foreign currency forward contracts was as follows:”

Table 26 after “The following amounts were recorded on the condensed consolidated balance sheets related to cumulative basis adjustments for fair value hedg”

Table 27 after “The effect of the cash flow hedges on other comprehensive loss and earnings for the periods presented was as follows:”

Table 28 after “Our debt consisted of the following:”

Table 29 after “Changes in the components of accumulated other comprehensive loss were as follows:”

Table 30 after “The following table provides a reconciliation of the weighted average number of shares outstanding used to compute basic and diluted EPS for”

Table 31 after “Supplementary cash flow information, and non-cash activities, for the periods presented was as follows:”

Table 32 after “Sold receivables activity for the period was as follows:”

Table 33 after “The following is a reconciliation of cash and cash equivalents, as reported within the condensed consolidated balance sheets, to the total c”

Table 34 after “The segment information for the periods presented was as follows:”

Table 35 after “The following table summarizes our condensed consolidated results of operations for the periods presented:”

Table 36 after “Segment and Corporate Results”

Table 37 after “The decrease in operating income for the three months ended April 3, 2020, as compared to the three months ended March 29, 2019, was primari”

Table 38 after “The increase in operating income for the three months ended April 3, 2020, as compared to the three months ended March 29, 2019, was primari”

Table 39 after “The increase in operating income for the three months ended April 3, 2020, as compared to the three months ended March 29, 2019, was primari”

Table 40 after “The estimated value of our total backlog was as follows:”

Table 41 after “The following table summarizes cash flow information for the periods presented:”

Table 42 after “The following table presents repurchases of Leidos common stock during the quarter ended April 3, 2020:”

Table 43 after “Exhibits.”